Influence of lithium cations on prolyl peptide bonds

Journal of Peptide Science

Volumn 18, Issue 6, 2012, Pages 400-404

  Kunz, Claudia ^a   Jahreis, Günther ^b   Günther, Robert ^a   Berger, Stefan ^a   Fischer, Gunter ^b   Hofmann, Hans Jörg ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b MAX PLANCK RESEARCH UNIT FOR ENZYMOLOGY OF PROTEIN FOLDING   (Germany)

Author keywords

Bipolar disorder; Cis trans isomerization; Lithium cation interactions; NMR spectroscopy; Prolyl peptide bonds

Indexed keywords

ACETONITRILE; LITHIUM; LITHIUM CATION; PEPTIDE; PROLINE DERIVATIVE; PROLYL PEPTIDE; TRIFLUOROETHANOL; UNCLASSIFIED DRUG; WATER;

AMINO ACID SEQUENCE; ARTICLE; CHEMICAL INTERACTION; CHEMICAL REACTION KINETICS; ENVIRONMENTAL FACTOR; ISOMERIZATION; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; THERMODYNAMICS;

ACETONITRILES; AMINO ACIDS; CATIONS; LITHIUM; PEPTIDES; STEREOISOMERISM; THERMODYNAMICS; TRIFLUOROETHANOL;

EID: 84861233883     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.2410     Document Type: Article

References (37)

1. Mitchell PB, Hadzi-Pavlovic D. Lithium treatment for bipolar disorder. Bull. World Health Organ. 2000; 78: 515-517.
2. Machado-Vieira R, Manji HK, Zarate, Jr CA. The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord. 2009; 11: 92-109.
3. Berridge MJ, Downes CP, Hanley MR. Neural and developmental actions of lithium: a unifying hypothesis. Cell 1989; 59: 411-419.
4. Ryves WJ, Harwood AJ. Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem. Biophys. Res. Commun. 2001; 280: 720-725.
5. Beaulieu JM, Sotnikova TD, Yao WD, Kockeritz L, Woodgett JR, Gainetdinov RR, Caron MG. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase-3 signaling cascade. Proc. Natl. Acad. Sci. 2004; 101: 5099-5104.
6. 2+ the underlying theme in the proposed mechanisms for the pharmacological action of lithium salts in bipolar disorder? Acc. Chem. Res. 2006; 39: 283-291.
7. Pasquali L, Busceti CL, Fulceri F, Paparelli A, Fornai F. Intracellular pathways underlying the effects of lithium. Behav. Pharmacol. 2010; 21: 473-492.
8. Ghasemi M, Sadeghipour H, Mosleh A, Sadeghipour HR, Mani AR, Dehpour AR. Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test. Eur. Neuropsychopharmacol. 2008; 18: 323-332.
9. Ghasemi M, Sadeghipour H, Poorheidari G, Dehpour AR. A role for nitrergic system in the antidepressant-like effects of chronic lithium treatment in the mouse forced swimming test. Behav. Brain Res. 2009; 200: 76-82.
10. Johnsson A, Engelmann W, Pflug B, Klemke W. Influence of lithium ions on human circadian-rhythms. Z. Naturforsch. C 1980; 35: 503-507.
11. Kripke DF, Wyborney VG. Lithium slows rat circadian activity rhythms. Life Sci. 1980; 26: 1319-1321.
12. Klemfuss H. Rhythms and the pharmacology of lithium. Pharmacol. Ther. 1992; 56: 53-78.
13. Marmol F. Lithium: bipolar disorder and neurodegenerative diseases. Possible cellular mechanisms of the therapeutic effects of lithium. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008; 32: 1761-1771.
14. Camins A, Verdaguer E, Junyent F, Yeste-Velasco M, Pelegri C, Vilaplana J, Pallas M. Potential mechanisms involved in the prevention of neurodegenerative diseases by lithium. CNS Neurosci. Ther. 2009; 15: 333-344.
15. McBride SMJ, Choi CH, Schoenfeld BP, Bell AJ, Liebelt DA, Ferreiro D, Choi RJ, Hinchey P, Kollaros M, Terlizzi AM, Ferrick NJ, Koenigsberg E, Rudominer RL, Sumida A, Chiorean S, Siwicki KK, Nguyen HT, Fortini ME, McDonald TV, Jongens TA. Pharmacological and genetic reversal of age-dependent cognitive deficits attributable to decreased presenilin function. J. Neurosci. 2010; 30: 9510-9522.
16. n (n=1, 2) - selective complexation of lithium ions (n=1) and potassium ions (n=2). J. Am. Chem. Soc. 1982; 104: 4534-4540.
17. Seebach D, Beck AK, Studer A. Modern Synthetic Methods, Vol. 7, Ernst B, Leumann C (eds). Basel/Weinheim: VHCA/VCH, 1995; 1-178.
18. Köck M, Kessler H, Seebach D, Thaler A. Novel backbone conformation of cyclosporine-A - the complex with lithium chloride. J. Am. Chem. Soc. 1992; 114: 2676-2686.
19. Kofron JL, Kuzmic P, Kishore V, Colon-Bonilla E, Rich DH. Determination of kinetic constants for peptidyl prolyl cis-trans isomerases by an improved spectophotometric assay. Biochemistry 1991; 30: 6127-6134.
20. Kofron JL, Kuzmic P, Kishore V, Gemmecker G, Fesik SW, Rich DH. Lithium chloride perturbation of cis-trans peptide bond equilibria - effect on conformational equilibria in cyclosporine-A and on time-dependent inhibition of cyclophilin. J. Am. Chem. Soc. 1992; 114: 2670-2675.
21. Pappenberger G, Aygün H, Engels JW, Reimer U, Fischer G, Kiefhaber T. Nonprolyl cis-peptide bonds in unfolded proteins cause complex folding kinetics. Nat. Struct. Biol. 2001; 8: 452-458.
22. Lummis SCR, Beene DL, Lee LW, Lester HA, Broadhurst RW, Dougherty DA. Cis-trans isomerization at a proline opens the pore of a neurotransmitter-gated ion channel. Nature 2005; 438: 248-252.
23. Melis C, Bussi G, Lummis SCR, Molteni C. Trans-cis switching mechanisms in proline analogues and their relevance for the gating of the 5-HT3 receptor. J. Phys. Chem. B 2009; 113: 12148-12153.
24. Fischer G, Bang H, Mech C. Detection of enzyme catalysis for cis-trans isomerization of peptide bonds using proline-containing peptides as substrates. Biomed. Biochim. Acta 1984; 43: 1101-1111.
25. Fischer G. Peptidyl-prolyl cis/trans isomerases and their effectors. Angew. Chem. Int. Ed. 1994; 33: 1415-1436.
26. Fischer S, Dunbrack, Jr. RL, Karplus M. Cis-trans imide isomerization of the proline dipeptide. J. Am. Chem. Soc. 1994; 116: 11931-11937.
27. Macura S, Ernst RR. Elucidation of cross relaxation in liquids by two-dimensional NMR spectroscopy. Mol. Phys. 1980; 41: 95-117.
28. Perrin CL, Gipe RK. Multisite kinetics by quantitative two-dimensional NMR. J. Am. Chem. Soc. 1984; 106: 4036-4038.
29. Aguirre G, Somanathan R, Hellberg LH, Dwyer TJ, North R. N-Alkenyl amide rotational barriers by 2D EXSY NMR. Magn. Reson. Chem. 2003; 41: 131-134.
30. Eigen M, Maeyer LD. Relaxation Methods, Friess S, Lewis E, Weissberger A (eds). New York: Interscience, 1963.
31. Cox C, Lectka T. Synthetic catalysis of amide isomerization. Acc. Chem. Res. 2000; 33: 849-858.
32. Hubner D, Drakenberg T, Forsén S, Fischer G. Peptidyl-prolyl cis-trans isomerase activity as studied by dynamic proton NMR spectroscopy. FEBS 1991; 284: 79-81.
33. Harrison RK, Stein RL. Mechanistic studies of enzymatic and nonenzymic prolyl cis-trans isomerization. J. Am. Chem. Soc. 1992; 114: 3464-3471.
34. Hur S, Bruice TC. The mechanism of cis-trans isomerization of prolyl peptides by cyclophilin. J. Am. Chem. Soc. 2002; 124: 7303-7313.
35. Kern D, Kern G, Scherer G, Fischer G, Drakenberg T. Kinetic analysis of cyclophilin-catalyzed prolyl cis/trans isomerization by dynamic NMR spectroscopy. Biochemistry 1995; 34: 13594-13602.
36. Reimer U, Scherer G, Drewello M, Kruber S, Schutkowski M, Fischer G. Side-chain effects on peptidyl-prolyl cis/trans isomerisation. J. Mol. Biol. 1998; 279: 449-460.
37. Zoldák G, Aumüller T, Lücke C, Hritz J, Ostenbrink C, Fischer G, Schmid FX. A library of fluorescent peptides for exploring the substrate specificities of prolyl isomerases. Biochemistry 2009; 48: 10423-10436.